Danske AI Virksomheder Logo
Virksomheder/Drug discovery AI/Synamics Therapeutics
Synamics Therapeutics
Drug discovery AI
København

Synamics Therapeutics

Drug discovery AI

Status: Redaktionelt indsamletSidst gennemgået: 2. april 2026
Besøg WebsiteOpgradér denne profil

Hvad er Synamics Therapeutics?

Synamics Therapeutics is a Danish AI-driven drug discovery startup pioneering Adaptive Medicine — the next generation of precision medicine. Through its proprietary platform Dynaptive™, the company designs therapies that anticipate and counteract disease evolution, specifically targeting drug resistance in cancer.

Synamics Therapeutics er en dansk AI-drevet drug discovery startup grundlagt i 2023, der udvikler Dynaptive™ — den første evolution-aware AI-platform der oversætter evolutionær biologi til lægemiddeldesign. Virksomheden bekæmper lægemiddelresistens i cancer ved at designe terapier der proaktivt adresserer resistensmekanismer.

Teknologier & Kompetencer

Drug discovery AIbiotech ML

Redaktionel metode & kilder

Vi udvælger virksomheder ud fra offentlig dokumentation, virksomhedens egne kanaler, research-noter og manuel redaktionel gennemgang. Oplysninger mærkes som verificeret af virksomheden eller redaktionelt indsamlet.

Profilen er redaktionelt indsamlet på baggrund af offentlige kilder og research-noter.

Produkt

Produktnavn
Dynaptive™

The first evolution-aware AI platform that translates insights from evolutionary biology into actionable drug design. Dynaptive anticipates how diseases evolve and designs therapies that preemptively address resistance mechanisms at the core of drug design, uniquely addressing the reasons why treatments fail.

Nøglefunktioner
Evolution-aware drug designAI-driven prediction of drug resistance mechanismsAdaptive therapy design that stays ahead of disease evolutionTranslational oncology integrationComputational drug optimization
Prismodel
B2B SaaS (not publicly disclosed)

Målgruppe & Kunder

Målindustrier
PharmaceuticalBiotechOncologyPrecision Medicine

Teknologi Stack

AI/MLEvolutionary biology modelingPredictive modelingComputational chemistryGenerative AI

Certificeringer & Awards

NVIDIA Inception ProgramDanish Bio (Dansk Biotek) memberPlug and Play portfolio company

Konkurrenter

Recursion PharmaceuticalsInsilico MedicineRelay TherapeuticsExscientiaBenevolentAIAtomwiseEilean Therapeutics

Ofte stillede spørgsmål om Synamics Therapeutics

What is Synamics Therapeutics?▼
A Danish AI-driven drug discovery startup founded in 2023, pioneering Adaptive Medicine to combat drug resistance in cancer through its Dynaptive™ platform.
What is Dynaptive™?▼
The first evolution-aware AI platform that translates evolutionary biology insights into drug design, anticipating how diseases evolve to preemptively address treatment failure.
Who founded Synamics Therapeutics?▼
Violet Zahedi (MD, CEO), Albert J. Kooistra (PhD, CTO), and Aaron Capar (MPPA, CBO and Board Chair).
Who are the investors?▼
Lead investors are Steen Riisgaard (former Novozymes CEO) and Per Falholt (former Novozymes CSO). Plug and Play Tech Center joined as the final pre-seed investor and is leading the seed round.
What diseases does Synamics focus on?▼
Primarily cancer — specifically drug-resistant cancers. The platform evolution-aware approach has potential applications across a broader range of diseases.
Where is Synamics Therapeutics based?▼
Incorporated in Copenhagen, Denmark (CVR 44258048), with operational presence in San Francisco, US.

Virksomhedsdata

  • LokationKøbenhavn, DK
  • BrancheDrug discovery AI
  • GrundlagtIgangværende system data-validering af infomation eller opdatering..
  • StiftereViolet Zahedi, Albert J. Kooistra, Aaron Capar
  • Medarbejdere12
  • FundingPre-seed closed jul. 2024 (lead: Steen Riisgaard & Per Falholt, former Novozymes executives); Seed round led by Plug and Play Tech Center
  • Investorer
    Steen RiisgaardPer FalholtPlug and Play Tech Center
  • PrismodelB2B SaaS (not publicly disclosed)
  • CVR-statusAktiv
  • VerificeretNej
  • ProfilstatusRedaktionelt indsamlet
  • Sidst gennemgåetapril 2026
Links
WebsiteLinkedIn

Brug for hjælp til at finde den rette AI-leverandør?

Vi matcher dig med op til 3 relevante virksomheder — gratis og uforpligtende.